{"id":17839,"title":"RTCTV catch up: Hemogenyx Pharmaceuticals (LON:HEMO)","publisher":"Share Talk","author":"sharetalk","published":"2017-11-21T17:37:10+00:00","modified":"2017-11-21T17:38:08+00:00","canonical_url":"https://www.share-talk.com/rtctv-catch-up-hemogenyx-pharmaceuticals-lonhemo/","markdown_url":"https://www.share-talk.com/rtctv-catch-up-hemogenyx-pharmaceuticals-lonhemo.md","json_url":"https://www.share-talk.com/rtctv-catch-up-hemogenyx-pharmaceuticals-lonhemo.json","category":"Healthcare","categories":["Healthcare"],"tags":["HEMO"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"We caught up again with Simon Campbell (Round the Clock Trader) and Zak Mir (Align Research) for another morning edition of Round the Clock Trader TV. This time we discuss Hemogenyx Pharmaceuticals Plc and their collaboration with the University of Oxford."}